Cafepharma Today

September 18 2024 - FDA scraps adcomm for Applied's rare disease drug ahead of November decision
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
Ascendis trial data piles pressure on BioMarin
Agency warns J&J over 340B rebate plan
GSK touts co-administration data for RSV, shingles vaccines
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Were Vytorin Cancer Data Made Public Too Soon?
WSJ Online
Wednesday, September 3, 2008 - 9:03am
tags:
Pfizer paying up to $725 million for Alzheimer drug rights
Marketwatch
Wednesday, September 3, 2008 - 8:52am
tags:
Novartis: Tekturna better than diuretic for obese patients
Marketwatch
Wednesday, September 3, 2008 - 8:48am
tags:
Vytorin Study's Ethical Morass
Forbes
Wednesday, September 3, 2008 - 8:47am
tags:
Has Lilly's Effient Been FDA Approved?
Seeking Alpha
Wednesday, September 3, 2008 - 8:46am
tags:
Teva sells Ivax Diagnostics stake
Globes Online, Israel
Wednesday, September 3, 2008 - 8:43am
tags:
Zentiva CEO tells shareholders to reject Sanofi bid
Reuters
Wednesday, September 3, 2008 - 8:43am
tags:
Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
Marketwatch
Wednesday, September 3, 2008 - 8:40am
tags:
Docs' caution over possible cholesterol drug-cancer link hurts Merck, Schering-Plough shares
Yahoo/AP
Tuesday, September 2, 2008 - 6:46pm
tags:
Shares of drug developer AtheroGenics fall after bond payment default
Yahoo/AP
Tuesday, September 2, 2008 - 6:45pm
tags:
King pays Pain Therapeutics $20 million
Yahoo/AP
Tuesday, September 2, 2008 - 6:44pm
tags:
Youth Suicides Rose After Stiffer Warnings Curbed Antidepressant Use
WSJ Online
Tuesday, September 2, 2008 - 6:40pm
tags:
Lipitor Is Back on the Tube
Motley Fool
Tuesday, September 2, 2008 - 6:39pm
tags:
Two Drug Companies For Easy-Mode Investors (BMY, LLY)
Investopedia
Tuesday, September 2, 2008 - 6:38pm
tags:
Drug maker Eli Lilly says long-acting version of Zyprexa shows low relapse rate
Yahoo/AP
Tuesday, September 2, 2008 - 6:38pm
tags:
Cardiologists Hate Vytorin
Motley Fool
Tuesday, September 2, 2008 - 6:37pm
tags:
Big Pharma Pipeline: Why So Dry?
Seeking Alpha
Tuesday, September 2, 2008 - 6:37pm
tags:
Fresenius buyout of APP Pharmaceuticals expected to clear by mid-September
Yahoo/AP
Tuesday, September 2, 2008 - 6:36pm
tags:
No Vindication For Vytorin; Victory for Sciele
CNBC
Tuesday, September 2, 2008 - 6:35pm
tags:
Eli Lilly says experimental blood thinner beat Plavix at stopping heart attacks in diabetics
Yahoo/AP
Tuesday, September 2, 2008 - 6:35pm
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information